The nucleocapsid protein of the SARS coronavirus is capable of self-association through a C-terminal 209 amino acid interaction domain
- PMID: 15094372
- PMCID: PMC7111157
- DOI: 10.1016/j.bbrc.2004.03.154
The nucleocapsid protein of the SARS coronavirus is capable of self-association through a C-terminal 209 amino acid interaction domain
Abstract
Severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) caused a severe outbreak in several regions of the world in 2003. The virus is a novel coronavirus isolated from patients exhibiting atypical pneumonia and may have originated from wild animals such as civet cats in southern China. The genome of SARS-CoV is a positive-sense, single-stranded RNA whose sequence is distantly related to all known coronaviruses that infect humans and animals. Like other known coronaviruses, SARS-CoV is an enveloped virus containing three outer structural proteins, namely the membrane (M), envelope (E), and spike (S) proteins. The nucleocapsid (N) protein together with the viral RNA genome presumably form a helical core located within the viral envelope. The SARS-CoV nucleocapsid (N) protein is a 423 amino-acid, predicted phospho-protein of 46 kDa that shares little homology with other members of the coronavirus family. A short serine-rich stretch, and a putative bipartite nuclear localization signal are unique to it, thus suggesting its involvement in many important functions during the viral life cycle. In this report we have cloned the N gene of the SARS coronavirus, and studied its property of self-association to form dimers. We expressed the N protein as a fusion protein in the yeast two-hybrid system to demonstrate self-association and confirmed dimerization of the N protein from mammalian cell lysates by coimmunoprecipitation. Furthermore, via deletion analysis, we have shown that the C-terminal 209 amino-acid region constitutes the interaction domain responsible for self-association of the N protein to form dimers.
Figures




Similar articles
-
Analysis of multimerization of the SARS coronavirus nucleocapsid protein.Biochem Biophys Res Commun. 2004 Apr 2;316(2):476-83. doi: 10.1016/j.bbrc.2004.02.074. Biochem Biophys Res Commun. 2004. PMID: 15020242 Free PMC article.
-
Carboxyl terminus of severe acute respiratory syndrome coronavirus nucleocapsid protein: self-association analysis and nucleic acid binding characterization.Biochemistry. 2006 Oct 3;45(39):11827-35. doi: 10.1021/bi0609319. Biochemistry. 2006. PMID: 17002283
-
SR-rich motif plays a pivotal role in recombinant SARS coronavirus nucleocapsid protein multimerization.Biochemistry. 2005 Nov 22;44(46):15351-8. doi: 10.1021/bi051122c. Biochemistry. 2005. PMID: 16285739
-
Properties of Coronavirus and SARS-CoV-2.Malays J Pathol. 2020 Apr;42(1):3-11. Malays J Pathol. 2020. PMID: 32342926 Review.
-
The SARS coronavirus nucleocapsid protein--forms and functions.Antiviral Res. 2014 Mar;103:39-50. doi: 10.1016/j.antiviral.2013.12.009. Epub 2014 Jan 11. Antiviral Res. 2014. PMID: 24418573 Free PMC article. Review.
Cited by
-
Incorporation of spike and membrane glycoproteins into coronavirus virions.Viruses. 2015 Apr 3;7(4):1700-25. doi: 10.3390/v7041700. Viruses. 2015. PMID: 25855243 Free PMC article. Review.
-
Whole genome sequencing of SARS-CoV2 strains circulating in Iran during five waves of pandemic.PLoS One. 2022 May 2;17(5):e0267847. doi: 10.1371/journal.pone.0267847. eCollection 2022. PLoS One. 2022. PMID: 35499994 Free PMC article.
-
Generation of human antibody fragments recognizing distinct epitopes of the nucleocapsid (N) SARS-CoV protein using a phage display approach.BMC Infect Dis. 2005 Sep 19;5:73. doi: 10.1186/1471-2334-5-73. BMC Infect Dis. 2005. PMID: 16171519 Free PMC article.
-
The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis.Int J Mol Sci. 2021 Jan 28;22(3):1308. doi: 10.3390/ijms22031308. Int J Mol Sci. 2021. PMID: 33525632 Free PMC article. Review.
-
A combined nucleocapsid vaccine induces vigorous SARS-CD8+ T-cell immune responses.Genet Vaccines Ther. 2005 Aug 22;3:7. doi: 10.1186/1479-0556-3-7. Genet Vaccines Ther. 2005. PMID: 16115319 Free PMC article.
References
-
- Buttner J. Evaluation of the diagnostic value of laboratory investigations. J. Clin. Chem. Clin Biochem. 1977;15:1–12. - PubMed
-
- A.T. Fleischauer, CDC SARS Investigative Team, Outbreak of severe acute respiratory syndrome—worldwide, Morb. Mortal Wkly. Rep. 52 (2003) 226–228 - PubMed
-
- Cumulative number of SARS probable cases in Taiwan, SARS Online Information Centre, Center for Disease Control, Taiwan [Accessed July 2, 2003]. Available from: URL: http:/www.cdc.gov.tw/sarsen
-
- Marra M.A, Jones S.J, Astell C.R, Holt R.A, Brooks-Wilson A, Butterfield Y.S, Khattra J, Asano J.K, Barber S.A, Chan S.Y, Cloutier A, Coughlin S.M, Freeman D, Girn N, Griffith O.L, Leach S.R, Mayo M, McDonald H, Montgomery S.B, Pandoh P.K, Petrescu A.S, Robertson A.G, Schein J.E, Siddiqui A, Smailus D.E, Stott J.M, Yang G.S, Plummer F, Andonov A, Artsob H, Bastien N, Bernard K, Booth T.F, Bowness D, Czub M, Drebot M, Fernando L, Flick R, Garbutt M, Gray M, Grolla A, Jones S, Feldmann H, Meyers A, Kabani A, Li Y, Normand S, Stroher U, Tipples G.A, Tyler S, Vogrig R, Ward D, Watson B, Brunham R.C, Krajden M, Petric M, Skowronski D.M, Upton C, Roper R.L. The genome sequence of the SARS-associated coronavirus. Science. 2003;300:1399–1404. - PubMed
-
- Rota P.A, Oberste M.S, Monroe S.S, Nix W.A, Campagnoli R, Icenogle J.P, Penaranda S, Bankamp B, Maher K, Chen M.H, Tong S, Tamin A, Lowe L, Frace M, DeRisi J.L, Chen Q, Wang D, Erdman D.D, Peret T.C, Burns C, Ksiazek T.G, Rollin P.E, Sanchez A, Liffick S, Holloway B, Limor J, McCaustland K, Olsen-Rasmussen M, Fouchier R, Gunther S, Osterhaus A.D, Drosten C, Pallansch M.A, Anderson L.J, Bellini W.J. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science. 2003;300:1394–1399. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous